BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,570
-70 (-0.60%)
Apr 28, 2026, 3:30 PM KST
-27.55%
Market Cap 368.48B
Revenue (ttm) 168.47B
Net Income (ttm) -3.23B
Shares Out 31.85M
EPS (ttm) -101.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 130,062
Average Volume 144,752
Open 11,690
Previous Close 11,640
Day's Range 11,530 - 11,740
52-Week Range 10,600 - 21,250
Beta 0.91
RSI 46.34
Earnings Date May 15, 2026

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

In 2025, BINEX's revenue was 168.47 billion, an increase of 29.55% compared to the previous year's 130.05 billion. Losses were -3.23 billion, -90.80% less than in 2024.

Financial Statements

News

There is no news available yet.